375 related articles for article (PubMed ID: 26290048)
21. Hedgehog signals inhibit postnatal beta cell neogenesis from adult rat exocrine pancreas in vitro.
Mfopou JK; Baeyens L; Bouwens L
Diabetologia; 2012 Apr; 55(4):1024-34. PubMed ID: 22237687
[TBL] [Abstract][Full Text] [Related]
22. Species differences in pancreatic binding of DO3A-VS-Cys
Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
[TBL] [Abstract][Full Text] [Related]
23. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.
Suarez-Pinzon WL; Power RF; Yan Y; Wasserfall C; Atkinson M; Rabinovitch A
Diabetes; 2008 Dec; 57(12):3281-8. PubMed ID: 18835930
[TBL] [Abstract][Full Text] [Related]
24. Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex.
Csajbók ÉA; Kocsis ÁK; Faragó N; Furdan S; Kovács B; Lovas S; Molnár G; Likó I; Zvara Á; Puskás LG; Patócs A; Tamás G
Diabetologia; 2019 Apr; 62(4):717-725. PubMed ID: 30637442
[TBL] [Abstract][Full Text] [Related]
25. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
26. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
Fan R; Li X; Gu X; Chan JC; Xu G
Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
[TBL] [Abstract][Full Text] [Related]
27. Sustained expression of GLP-1 receptor differentially modulates β-cell functions in diabetic and nondiabetic mice.
Kubo F; Miyatsuka T; Sasaki S; Takahara M; Yamamoto Y; Shimo N; Watada H; Kaneto H; Gannon M; Matsuoka TA; Shimomura I
Biochem Biophys Res Commun; 2016 Feb; 471(1):68-74. PubMed ID: 26854076
[TBL] [Abstract][Full Text] [Related]
28. Synergistic endocrine induction by GLP-1 and TGF-beta in the developing pancreas.
Tei E; Mehta S; Tulachan SS; Yew H; Hembree M; Preuett B; Snyder CL; Yamataka A; Miyano T; Gittes GK
Pancreas; 2005 Aug; 31(2):138-41. PubMed ID: 16025000
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
Hou Y; Ernst SA; Heidenreich K; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
[TBL] [Abstract][Full Text] [Related]
30. Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells.
Lima MJ; Muir KR; Docherty HM; Drummond R; McGowan NW; Forbes S; Heremans Y; Houbracken I; Ross JA; Forbes SJ; Ravassard P; Heimberg H; Casey J; Docherty K
Diabetes; 2013 Aug; 62(8):2821-33. PubMed ID: 23610058
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
[TBL] [Abstract][Full Text] [Related]
32. GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts.
Xu G; Kaneto H; Lopez-Avalos MD; Weir GC; Bonner-Weir S
Diabetes Res Clin Pract; 2006 Jul; 73(1):107-10. PubMed ID: 16406191
[No Abstract] [Full Text] [Related]
33. Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
Brill AL; Wisinski JA; Cadena MT; Thompson MF; Fenske RJ; Brar HK; Schaid MD; Pasker RL; Kimple ME
Mol Endocrinol; 2016 May; 30(5):543-56. PubMed ID: 27049466
[TBL] [Abstract][Full Text] [Related]
34. COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways.
Boutant M; Ramos OH; Tourrel-Cuzin C; Movassat J; Ilias A; Vallois D; Planchais J; Pégorier JP; Schuit F; Petit PX; Bossard P; Maedler K; Grapin-Botton A; Vasseur-Cognet M
PLoS One; 2012; 7(1):e30847. PubMed ID: 22292058
[TBL] [Abstract][Full Text] [Related]
35. Reprogramming of enteroendocrine K cells to pancreatic β-cells through the combined expression of Nkx6.1 and Neurogenin3, and reaggregation in suspension culture.
Lee E; Ryu GR; Moon SD; Ko SH; Ahn YB; Song KH
Biochem Biophys Res Commun; 2014 Jan; 443(3):1021-7. PubMed ID: 24365150
[TBL] [Abstract][Full Text] [Related]
36. The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats.
Skarbaliene J; Secher T; Jelsing J; Ansarullah ; Neerup TS; Billestrup N; Fosgerau K
Peptides; 2015 Jul; 69():47-55. PubMed ID: 25849341
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.
Dai C; Hang Y; Shostak A; Poffenberger G; Hart N; Prasad N; Phillips N; Levy SE; Greiner DL; Shultz LD; Bottino R; Kim SK; Powers AC
J Clin Invest; 2017 Oct; 127(10):3835-3844. PubMed ID: 28920919
[TBL] [Abstract][Full Text] [Related]
38. Direct lineage conversion of pancreatic exocrine to endocrine Beta cells in vivo with defined factors.
Cavelti-Weder C; Li W; Weir GC; Zhou Q
Methods Mol Biol; 2014; 1150():247-62. PubMed ID: 24744004
[TBL] [Abstract][Full Text] [Related]
39. β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control.
Gleizes C; Kreutter G; Abbas M; Kassem M; Constantinescu AA; Boisramé-Helms J; Yver B; Toti F; Kessler L
J Cell Mol Med; 2016 Feb; 20(2):231-42. PubMed ID: 26607759
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
Hao T; Zhang H; Li S; Tian H
Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
